These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 22201711)

  • 1. Pretargeted radioimmunotherapy with α-particle emitting radionuclides.
    Lindegren S; Frost SH
    Curr Radiopharm; 2011 Jul; 4(3):248-60. PubMed ID: 22201711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted alpha therapy: part I.
    Elgqvist J
    Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretargeted radioimmunotherapy of cancer: progress step by step.
    Boerman OC; van Schaijk FG; Oyen WJ; Corstens FH
    J Nucl Med; 2003 Mar; 44(3):400-11. PubMed ID: 12621007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The promise of targeted {alpha}-particle therapy.
    Mulford DA; Scheinberg DA; Jurcic JG
    J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunotherapy with alpha-particle emitting radionuclides.
    Zalutsky MR; Pozzi OR
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant bispecific monoclonal antibodies prepared by the dock-and-lock strategy for pretargeted radioimmunotherapy.
    Sharkey RM; Rossi EA; McBride WJ; Chang CH; Goldenberg DM
    Semin Nucl Med; 2010 May; 40(3):190-203. PubMed ID: 20350628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts.
    Heskamp S; Hernandez R; Molkenboer-Kuenen JDM; Essler M; Bruchertseifer F; Morgenstern A; Steenbergen EJ; Cai W; Seidl C; McBride WJ; Goldenberg DM; Boerman OC
    J Nucl Med; 2017 Jun; 58(6):926-933. PubMed ID: 28232604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunotherapy with α-particle-emitting radionuclides.
    Seidl C
    Immunotherapy; 2014; 6(4):431-58. PubMed ID: 24815783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
    Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A
    Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCs of radioisotopes used for radioimmunotherapy: alpha- and beta-emitters.
    Waldmann T
    Leuk Lymphoma; 2003; 44 Suppl 3():S107-13. PubMed ID: 15202533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer radioimmunotherapy with alpha-emitting nuclides.
    Couturier O; Supiot S; Degraef-Mougin M; Faivre-Chauvet A; Carlier T; Chatal JF; Davodeau F; Cherel M
    Eur J Nucl Med Mol Imaging; 2005 May; 32(5):601-14. PubMed ID: 15841373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in pretargeted radioimmunotherapy.
    Gruaz-Guyon A; Raguin O; Barbet J
    Curr Med Chem; 2005; 12(3):319-38. PubMed ID: 15723622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunotherapy with alpha-emitting nuclides.
    McDevitt MR; Sgouros G; Finn RD; Humm JL; Jurcic JG; Larson SM; Scheinberg DA
    Eur J Nucl Med; 1998 Sep; 25(9):1341-51. PubMed ID: 9724387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
    Sharkey RM; Karacay H; Richel H; McBride WJ; Rossi EA; Chang K; Yeldell D; Griffiths GL; Hansen HJ; Goldenberg DM
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3897S-913S. PubMed ID: 14506188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Radioimmunotherapy and Theranostics with Alpha Emitters.
    Pandit-Taskar N
    J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S41-S44. PubMed ID: 31451417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods.
    Sharkey RM; Karacay H; Cardillo TM; Chang CH; McBride WJ; Rossi EA; Horak ID; Goldenberg DM
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7109s-7121s. PubMed ID: 16203810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons.
    Aghevlian S; Boyle AJ; Reilly RM
    Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretargeted imaging and radioimmunotherapy of cancer using antibodies and bioorthogonal chemistry.
    van de Watering FC; Rijpkema M; Robillard M; Oyen WJ; Boerman OC
    Front Med (Lausanne); 2014; 1():44. PubMed ID: 25593917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretargeted alpha emitting radioimmunotherapy using (213)Bi 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid-biotin.
    Yao Z; Zhang M; Garmestani K; Axworthy DB; Mallett RW; Fritzberg AR; Theodore LJ; Plascjak PS; Eckelman WC; Waldmann TA; Pastan I; Paik CH; Brechbiel MW; Carrasquillo JA
    Clin Cancer Res; 2004 May; 10(9):3137-46. PubMed ID: 15131055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein targeting constructs in alpha therapy.
    Olafsen T; Elgqvist J; Wu AM
    Curr Radiopharm; 2011 Jul; 4(3):197-213. PubMed ID: 22201709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.